Navigation Links
Varian and Siemens to Showcase Collaborative Offerings at 2013 ASTRO Meeting in Atlanta
Date:9/20/2013

ATLANTA, Sept. 20, 2013 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) and Siemens Healthcare will showcase a variety of solutions that bring together Siemens' world-class diagnostic imaging technologies with Varian's advanced therapeutic systems for treating cancer with image-guided radiotherapy, radiosurgery, and brachytherapy at the 54th annual meeting of the American Society for Radiation Oncology (ASTRO) starting here this Sunday. 

Connecting Varian's ARIA® Software to Siemens Linear Accelerators

As part of their EnVision Better Cancer Care global strategic partnership, the two companies will showcase Varian Exchange, a new interface for connecting Varian's ARIA® oncology information system with Siemens' ARTISTE medical linear accelerators.1

Earlier this year, Varian and Siemens announced an interface that connected ARIA with Siemens' ONCOR and PRIMUS accelerators.  "That first phase of interface development enabled us to connect ARIA with about 80 percent of Siemens treatment machines," said Karla Donohoe, vice president of strategic planning for Varian's Oncology Systems business.  "With this new interface, we will have connectivity available for a full range of Siemens treatment machines, allowing us to offer a seamless solution for using them with ARIA to deliver quality cancer care."

Varian Brachytherapy Powered by Siemens Sliding Gantry Imaging

Varian and Siemens will also showcase the pairing of a Siemens SOMATOM CT Sliding Gantry scanner with Varian brachytherapy technology to enable 3-D image-guided high-dose-rate (HDR) brachytherapy procedures within a single treatment room. 

HDR brachytherapy involves delivering radiotherapy from inside the body by temporarily placing a tiny radioactive source directly into the tumor or other targeted area. Using a robotic device called an afterloader, clinicians place the radioactive source into positions through applicators that have been inserted into the area being treated.

"HDR brachytherapy treatments are planned using anatomical images of the targeted area taken after applicators have been put in place," said Tim Clark, marketing manager for Varian BrachyTherapy.  "The Siemens Sliding Gantry CT is ideal for use right in the brachytherapy treatment room, so the patient doesn't have to be moved to another room for scanning.  It has the potential to minimize patient transport and possible applicator motion, which could compromise accuracy.  Image quality is much superior to what is possible using conventional X-rays or ultrasound imaging."

Respiratory Gating and CT Imaging

Varian and Siemens will also showcase the interoperability of a Siemens' CT scanner with Varian's Real-time Position Management™ (RPM) system. The brand new Biograph mCT Flow PET/CT scanner that Siemens will unveil at ASTRO also works in conjunction with Varian's RPM system.

"The RPM system, when used in conjunction with imaging, enables clinicians to understand how a tumor moves during a treatment," says Donohoe.  "This makes it possible to compensate for tumor motion while planning and delivering radiotherapy treatments in the lung and other parts of the body that are subject to respiratory motion.  By using these technologies together, cancer specialists can design and deliver treatments that minimize exposure of healthy tissues."

Varian and Siemens technology will be showcased in both companies' exhibits at the ASTRO meeting taking place Sept. 22-25 at the Georgia World Congress Center in Atlanta.  Siemens will be in booth #929; Varian in booth #1115.

1 Pending FDA clearance and not commercially available in the U.S. Due to regulatory reasons, future availability cannot be guaranteed.

About Varian Medical Systems
Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes, digital detectors, and image processing workstations for X-ray imaging in medical, scientific, and industrial applications and also supplies high-energy X-ray devices for cargo screening and non-destructive testing applications.  Varian Medical Systems employs approximately 6350 people who are located at manufacturing sites in North America, Europe, and China and approximately 70 sales and support offices around the world. For more information, visit http://www.varian.com or follow us on Twitter.

FOR INFORMATION CONTACT:

Varian Medical Systems, United States
Meryl Ginsberg, 650.424.6444
meryl.ginsberg@varian.com


'/>"/>
SOURCE Varian Medical Systems
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. CIVCOs Protura and Varian Integration Keeps Motion Management Clearly on Target at ASTRO 2013
2. Varian Medical Systems Publishes 2013 Sustainability Report Outlining Environmental, Charitable, Safety and Health Access Achievements
3. Varian Medical Systems Schedules Investor Meeting at ASTRO in Atlanta
4. The Majority of Surveyed Oncologists Prescribe Avastin Off-label to Their Ovarian Cancer Patients; However Approximately Half Encounter Access and Reimbursement Hurdles
5. Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2013
6. Supreme Court Ruling Today Allows DNATraits to Offer Low Cost BRCA Breast and Ovarian Cancer Gene Testing in U.S.
7. Varian Software Successfully Connected with Siemens Linear Accelerators
8. Amgen Announces Top-Line Results Of Phase 3 Trebananib (AMG 386) TRINOVA-1 Trial In Recurrent Ovarian Cancer
9. Emerging Targeted Therapies Offer Efficacy Advantages Over Currently Used Chemotherapies for Platinum-Resistant Advanced Ovarian Cancer
10. Preclinical and Phase 1 Data of VTX-2337 Presented at 2013 ASCO Annual Meeting Shows Early Activity in Ovarian Cancer
11. Varian Medical Systems Receives FDA 510(k) Clearance of its Nexus DRF Digital X-Ray Imaging System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... , Dec. 5, 2016   Lexicon Pharmaceuticals, ... results today from a Phase 2 clinical study of ... Lexicon in collaboration with JDRF, the leading global organization ... of this Phase 2 clinical trial, which randomized a ... of a once-daily 400 mg dose of sotagliflozin compared ...
(Date:12/5/2016)... , December 5, 2016 According to ... Treatment modalities (Chondrocyte Transplantation, Growth Factor Technology, Tissue Scaffolds, Cell-free composites), ... by MarketsandMarkets, the market is projected to reach USD 779.8 Million ... CAGR of 13.5% during the forecast period of 2016 to 2021. ... ...
(Date:12/5/2016)... PORTLAND, Oregon and PUNE, India ... a new report by Allied Market Research, titled, "Global Cancer ... the global revenue of cancer biomarkers market is projected to ... at a CAGR of 13.3% from 2016 to 2022. Omic ... share in 2015 and is expected to maintain its dominance ...
Breaking Medicine Technology:
(Date:12/6/2016)... , ... December 06, 2016 ... ... on Friday, November 25th, when SevenPoint2 released the much-anticipated HydroFX for Water®. ... eye-catching label design. Featuring one of the world’s most powerful antioxidants, molecular ...
(Date:12/6/2016)... ... December 06, 2016 , ... TopConsumerReviews.com recently gave a ... Scooters . , Mobility Scooters give freedom to people who need help getting around. ... may be facing a long period of rehabilitation after an illness or accident. There ...
(Date:12/5/2016)... ... December 05, 2016 , ... "FCPX Overlay Glare is a ... lighting effect without heavy rendering or complicated compositing," said Christina Austin - CEO of ... create an organic spectrum of lights that simulates the look of a glare. ...
(Date:12/5/2016)... GA (PRWEB) , ... December ... ... technology and security executive networking and relationship-marketing firm, announced today that nominations ... the 2017 Information Security Executive® (ISE®) Central Awards. , Awards include the ...
(Date:12/5/2016)... ... December 05, 2016 , ... Physicians Education ... Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma, on ... “We are honored to have Amy E. Herman present at this year’s conference, ...
Breaking Medicine News(10 mins):